This confirms what we already knew…
As reported today at the European Society of Cardiology in Amsterdam:
“Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of all women with AF should be reviewed to ensure they are receiving anticoagulation, if appropriate, according to the CHA2DS2-VASc score.”
See: GPs undertreat women with AF
Leave a Reply